The Fine LINE: Methylation Drawing the Cancer Landscape

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Miousse, Isabelle R ^a   Koturbash, Igor ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; DNA;

BODY FLUID; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DNA METHYLATION; GENE CONTROL; GENE EXPRESSION; GENOME; HUMAN; LINE 1 TRANSPOSON; METASTASIS; NEOPLASM; RETROPOSON; REVIEW; TRANSPOSON; ANIMAL; GENETICS; LONG INTERSPERSED REPEAT; METABOLISM; PATHOLOGY;

ANIMALS; DNA METHYLATION; DNA, NEOPLASM; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; NEOPLASMS;

EID: 84939469319     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/131547     Document Type: Review

References (86)

1. E. M. Ostertag and H. H. Kazazian Jr., "Biology of mammalian L1 retrotransposons," Annual Review of Genetics, vol. 35, pp. 501-538, 2001.
2. K. H. Burns and J. D. Boeke, "Human transposon tectonics," Cell, vol. 149, no. 4, pp. 740-752, 2012.
3. M. Cowley and R. J.Oakey, "Transposable elements re-wire and fine-tune the transcriptome," PLoS Genetics, vol. 9, no. 1,Article ID e1003234, 2013.
4. E. Belan, "LINEs of evidence: noncanonical DNA replication as an epigenetic determinant," Biology Direct, vol. 8, article 22, 2013.
5. Y. Zhang, I. A. Maksakova, L. Gagnier, L. N. van de Lagemaat, and D. L. Mager, "Genome-wide assessments reveal extremely high levels of polymorphism of two active families of mouse endogenous retroviral elements," PLoS Genetics, vol. 4, no. 2, Article ID e1000007, 2008.
6. R. E.Mills, E. A. Bennett, R. C. Iskow, and S. E. Devine, "Which transposable elements are active in the human genome?" Trends in Genetics, vol. 23, no. 4, pp. 183-191, 2007.
7. H. S. Malik, W. D. Burke, and T. H. Eickbush, "The age and evolution of non-LTR retrotransposable elements," Molecular Biology and Evolution, vol. 16, no. 6, pp. 793-805, 1999.
8. A. F. Smit, "Interspersed repeats and other mementos of transposable elements in mammalian genomes," Current Opinion in Genetics and Development, vol. 9, no. 6, pp. 657-663, 1999.
9. E. S. Lander, L. M. Linton, B. Birren et al., "Initial sequencing and analysis of the human genome," Nature, vol. 409, no. 6822, pp. 860-921, 2001.
10. Q. Feng, J. V. Moran, H. H. Kazazian Jr., and J. D. Boeke, "Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition," Cell, vol. 87, no. 5, pp. 905-916, 1996.
11. G. J. Cost, Q. Feng, A. Jacquier, and J. D. Boeke, "Human L1 element target-primed reverse transcription in vitro," The EMBO Journal, vol. 21, no. 21, pp. 5899-5910, 2002.
12. T. Tchénio, J.-F. Casella, and T. Heidmann, "Members of the SRY family regulate the human LINE retrotransposons," Nucleic Acids Research, vol. 28, no. 2, pp. 411-415, 2000.
13. N. Yang, L. Zhang, Y. Zhang, and H. H. Kazazian Jr., "An important role for RUNX3 in human L1 transcription and retrotransposition," Nucleic Acids Research, vol. 31, no. 16, pp. 4929-4940, 2003.
14. C. R. Harris, A. Dewan, A. Zupnick et al., "P53 responsive elements in human retrotransposons," Oncogene, vol. 28, no. 44, pp. 3857-3865, 2009.
15. K. Mätlik, K. Redik, and M. Speek, "L1 antisense promoter drives tissue-specific transcription of human genes," Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 71753, 16 pages, 2006.
16. H. A. Cruickshanks, N. Vafadar-Isfahani, D. S. Dunican et al., "Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer," Nucleic Acids Research, vol. 41, no. 14, pp. 6857-6869, 2013.
17. N. Yang and H. H. Kazazian Jr., "L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs inhuman cultured cells,"Nature Structural&Molecular Biology, vol. 13, no. 9, pp. 763-771, 2006.
18. J. Li, M. Kannan, A. L. Trivett et al., "An antisense promoter in mouse L1 retrotransposon open reading frame-1 initiates expression of diverse fusion transcripts and limits retrotransposition," Nucleic Acids Research, vol. 42, no. 7, pp. 4546-4562, 2014.
19. A. R. Muotri, M. C. N. Marchetto, N. G. Coufal et al., "L1 retrotransposition in neurons ismodulated byMeCP2," Nature, vol. 468, no. 7322, pp. 443-446, 2010.
20. J. K. Baillie, M. W. Barnett, K. R. Upton et al., "Somatic retrotransposition alters the genetic landscape of the human brain," Nature, vol. 479, no. 7374, pp. 534-537, 2011.
21. A.D. Ewing and H. H. Kazazian Jr., "Whole-genome resequencing allows detection of many rare LINE-1 insertion alleles in humans," Genome Research, vol. 21, no. 6, pp. 985-990, 2011.
22. J. Xing, Y. Zhang, K. Han et al., "Mobile elements create structural variation: analysis of a complete human genome," Genome Research, vol. 19, no. 9, pp. 1516-1526, 2009.
23. H. Hohjoh and M. F. Singer, "Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA," The EMBO Journal, vol. 15, no. 3, pp. 630-639, 1996.
24. D. A. Kulpa and J. V. Moran, "Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles," Nature Structural and Molecular Biology, vol. 13, no. 7, pp. 655-660, 2006.
25. P. A. Jones and G. Liang, "Rethinking how DNA methylation patterns are maintained," Nature Reviews Genetics, vol. 10, no. 11, pp. 805-811, 2009.
26. R. A. Rollins, F. Haghighi, J. R. Edwards et al., "Large-scale structure of genomic methylation patterns," Genome Research, vol. 16, no. 2, pp. 157-163, 2006.
27. I. Koturbash, A. Boyko, R. Rodriguez-Juarez et al., "Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo," Carcinogenesis, vol. 28, no. 8, pp. 1831-1838, 2007.
28. B.Weber, S. Kimhi, G.Howard, A. Eden, and F. Lyko, "Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signalling through induction of illegitimate transcription," Oncogene, vol. 29, no. 43, pp. 5775-5784, 2010.
29. J.M. Tubio, Y. Li, Y. S. Ju et al., "Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes," Science, vol. 345, no. 6196, Article ID 1251343, 2014.
30. G. Liang, M. F. Chan, Y. Tomigahara et al., "Cooperativity between DNA methyltransferases in the maintenance methylation of repetitive elements,"Molecular and Cellular Biology, vol. 22, no. 2, pp. 480-491, 2002.
31. J. L. Garcia-Perez, M. Morell, J. O. Scheys et al., "Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells," Nature, vol. 466, no. 7307, pp. 769-773, 2010.
32. M. A. Carmell, A. Girard, H. J. G. van de Kant et al., "MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline," Developmental Cell, vol. 12, no. 4, pp. 503-514, 2007.
33. J. P. Ross, K. N. Rand, and P. L. Molloy, "Hypomethylation of repeated DNA sequences in cancer," Epigenomics, vol. 2, no. 2, pp. 245-269, 2010.
34. H. H. Kazazian Jr., C. Wong, H. Youssoufian, A. F. Scott, D. G. Phillips, and S. E. Antonarakis, "Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man," Nature, vol. 332, no. 6160, pp. 164-166, 1988.
35. C. R. Beck, J. L. Garcia-Perez, R. M. Badge, and J. V. Moran, "LINE-1 elements in structural variation and disease," Annual Review of Genomics and Human Genetics, vol. 12, pp. 187-215, 2011.
36. D. C. Hancks and H. H. Kazazian, "Active human retrotransposons: variation and disease," Current Opinion in Genetics and Development, vol. 22, no. 3, pp. 191-203, 2012.
37. Y.Miki, I. Nishisho, A.Horii et al., "Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer," Cancer Research, vol. 52, no. 3, pp. 643-645, 1992.
38. R.C. Iskow,M. T.McCabe, R. E. Mills et al., "Natural mutagenesis of human genomes by endogenous retrotransposons," Cell, vol. 141, no. 7, pp. 1253-1261, 2010.
39. E. Lee, R. Iskow, L. Yang et al., "Landscape of somatic retrotransposition in human cancers," Science, vol. 337, no. 6097, pp. 967-971, 2012.
40. S. Solyom, A. D. Ewing, E. P. Rahrmann et al., "Extensive somatic L1 retrotransposition in colorectal tumors," Genome Research, vol. 22, no. 12, pp. 2328-2338, 2012.
41. A. P. Feinberg and B. Vogelstein, "Hypomethylation distinguishes genes of some human cancers from their normal counterparts," Nature, vol. 301, no. 5895, pp. 89-92, 1983.
42. M. Ehrlich, M. A. Gama-Sosa, L.-H. Huang et al., "Amount and distribution of 5-methylcytosine in human DNA fromdifferent types of tissues or cells," Nucleic Acids Research, vol. 10, no. 8, pp. 2709-2721, 1982.
43. S. B. Baylin, J.W. M. Hoppener, A. de Bustros, P. H. Steenbergh, C. J. Lips, and B. D. Nelkin, "DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas," Cancer Research, vol. 46, no. 6, pp. 2917-2922, 1986.
44. P. A. Jones, M. J.Wolkowicz,W. M. Rideout III et al., "De novo methylation of theMyoD1 CpG island during the establishment of immortal cell lines," Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 16, pp. 6117-6121, 1990.
45. A. Portela and M. Esteller, "Epigenetic modifications and human disease," Nature Biotechnology, vol. 28, no. 10, pp. 1057-1068, 2010.
46. K. Hur, P. Cejas, J. Feliu et al., "Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis," Gut, vol. 63, pp. 635-646, 2014.
47. Y. Zhang, J. Shu, J. Si, L. Shen, M. R. H. Estecio, and J.-P. J. Issa, "Repetitive elements and enforced transcriptional repression co-operate to enhance DNA methylation spreading into a promoter CpG-island," Nucleic Acids Research, vol. 40, no. 15, pp. 7257-7268, 2012.
48. I. K. Jordan, I. B. Rogozin, G. V. Glazko, and E. V. Koonin, "Origin of a substantial fraction of human regulatory sequences from transposable elements," Trends in Genetics, vol. 19, no. 2, pp. 68-72, 2003.
49. K. Ikeda, K. Shiraishi, A. Eguchi et al., "Long interspersed nucleotide element 1 hypomethylation is associated with poor prognosis of lung adenocarcinoma," Annals ofThoracic Surgery, vol. 96, no. 5, pp. 1790-1794, 2013.
50. K. Harada, Y. Baba, T. Ishimoto et al., "LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas," Annals of Surgical Oncology, 2014.
51. X.-D. Gao, J.-H. Qu, X.-J. Chang et al., "Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma," Liver International, vol. 34, no. 1, pp. 136-146, 2014.
52. C. Zhu, T. Utsunomiya, T. Ikemoto et al., "Hypomethylation of long interspersed nuclear element-1 (LINE-1) is associated with poor prognosis via activation of c-MET in hepatocellular carcinoma," Annals of Surgical Oncology, vol. 21, no. 4, supplement, pp. 729-735, 2014.
53. A. Benard, C. J. H. Van De Velde, L. Lessard et al., "Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer," British Journal of Cancer, vol. 109, no. 12, pp. 3073-3083, 2013.
54. L. Sigalotti, E. Fratta, E. Bidoli et al., "Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients," Journal of Translational Medicine, vol. 9, article 78, 2011.
55. S. Hoshimoto, C. T. Kuo, K. K. Chong et al., "AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome," Journal of Investigative Dermatology, vol. 132, no. 6, pp. 1689-1697, 2012.
56. S. I. Ecsedi, H. Hernandez-Vargas, S. C. Lima, Z. Herceg, R. Adany, and M. Balazs, "Transposable hypomethylation is associated with metastatic capacity of primary melanomas," International Journal of Clinical and Experimental Pathology, vol. 6, no. 12, pp. 2943-2948, 2013.
57. M. R. H. Estécio, V. Gharibyan, L. Shen et al., "LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability," PLoS ONE, vol. 2, no. 5, article e399, 2007.
58. A. Matsunoki, K. Kawakami, M. Kotake et al., "LINE-1 methylation shows little intra-patient heterogeneity in primary and synchronousmetastatic colorectal cancer," BMC Cancer, vol. 12, article 574, 2012.
59. S. Y. Park, A. N. Seo, H. Y. Jung et al., "Alu and LINE-1 hypomethylation is associated withHER2 enriched subtype of breast cancer," PLoS ONE, vol. 9, no. 6,Article ID e100429, 2014.
60. A. Senthong, N. Kitkumthorn, P. Rattanatanyong, N. Khemapech, S. Triratanachart, and A. Mutirangura, "Differences in LINE-1 methylation between endometriotic ovarian cyst and endometriosis-associated ovarian cancer," International Journal of Gynecological Cancer, vol. 24, no. 1, pp. 36-42, 2014.
61. G. P. Dotto, "Multifocal epithelial tumors and field cancerization: stroma as a primary determinant," Journal of Clinical Investigation, vol. 124, no. 4, pp. 1446-1453, 2014.
62. Y. Luo, M. Yu, and W. M. Grady, "Field cancerization in the colon: a role for aberrant DNA methylation?" Gastroenterology Report (Oxford), vol. 2, pp. 16-20, 2014.
63. T. Ushijima, "Epigenetic field for cancerization: its cause and clinical implications," BMC Proceedings, vol. 7, supplement 2, article K22, 2013.
64. T. Ushijima, "Epigenetic field for cancerization," Journal of Biochemistry and Molecular Biology, vol. 40, no. 2, pp. 142-150, 2007.
65. H. Kamiyama, K. Suzuki, T.Maeda et al., "DNA demethylation in normal colon tissue predicts predisposition to multiple cancers," Oncogene, vol. 31, no. 48, pp. 5029-5037, 2012.
66. W. Pavicic, E. I. Joensuu, T.Nieminen, and P. Peltomäki, "LINE-1 hypomethylation in familial and sporadic cancer," Journal of Molecular Medicine, vol. 90, no. 7, pp. 827-835, 2012.
67. H. Shigaki, Y. Baba, M. Watanabe et al., "LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history," Annals of Surgical Oncology, vol. 19, no. 13, pp. 4238-4243, 2012.
68. K.Saito,K.Kawakami, I.Matsumoto,M.Oda,G.Watanabe, and T. Minamoto, "Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer," Clinical Cancer Research, vol. 16, no. 8, pp. 2418-2426, 2010.
69. S. Iwagami, Y. Baba, M. Watanabe et al., "LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma," Annals of Surgery, vol. 257, no. 3, pp. 449-455, 2013.
70. S. M. Tajuddin, A. F. Amaral, A. F. Fernandez et al., "Malats N: LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk," British Journal of Cancer, vol. 110, pp. 2123-2130, 2014.
71. L. Pergoli, C. Favero, R. M. Pfeiffer et al., "Blood DNA methylation, nevi number, and the risk of melanoma," Melanoma Research, vol. 24, pp. 480-487, 2014.
72. A. Dauksa, A. Gulbinas, Z. Endzinas, J. Oldenburg, and O. El-Maarri, "DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer," Anticancer Research, vol. 34, no. 10, pp. 5381-5388, 2014.
73. R. E. Neale, P. J. Clark, J. Fawcett et al., "Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer," Cancer Epidemiology, vol. 38, no. 5, pp. 576-582, 2014.
74. M. Barchitta, A. Quattrocchi, A. Maugeri, M. Vinciguerra, and A.Agodi, "LINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis," PLoS ONE, vol. 9, no. 10, Article ID e109478, 2014.
75. V. P. Belancio, A. M. Roy-Engel, R. R. Pochampally, and P. Deininger, "Somatic expression of LINE-1 elements in human tissues," Nucleic Acids Research, vol. 38, no. 12, pp. 3909-3922, 2010.
76. D. T. Ting, D. Lipson, S. Paul et al., "Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers," Science, vol. 331, no. 6017, pp. 593-596, 2011.
77. C. R. Harris, R. Normart, Q. Yang et al., "Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumorswith poor prognostic outcomes,"Genes&Cancer, vol. 1, no. 2, pp. 115-124, 2010.
78. L. Chen, J. E. Dahlstrom, A. Chandra, P. Board, and D. Rangasamy, "Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer," Breast Cancer Research and Treatment, vol. 136, no. 1,pp. 129-142, 2012.
79. C. Phokaew, S. Kowudtitham, K. Subbalekha, S. Shuangshoti, and A. Mutirangura, "LINE-1 methylation patterns of different loci in normal and cancerous cells," Nucleic Acids Research, vol. 36, no. 17, pp. 5704-5712, 2008.
80. A. Daskalos, G. Nikolaidis, G. Xinarianos et al., "Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer," International Journal of Cancer, vol. 124, no. 1, pp. 81-87, 2009.
81. S. Fabris, V. Bollati, L. Agnelli et al., "Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia," Epigenetics, vol. 6, no. 2, pp. 188-194, 2011.
82. H. C. Si, S. Worswick, H.-M. Byun et al., "Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer," International Journal of Cancer, vol. 125, no. 3, pp. 723-729, 2009.
83. S. Szpakowski, X. Sun, J. M. Lage et al., "Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements," Gene, vol. 448, no. 2, pp. 151-167, 2009.
84. H.-M. Byun,V.Motta, T. Panni et al., "Evolutionary age of repetitive element subfamilies and sensitivity of DNAmethylation to airborne pollutants," Particle and Fibre Toxicology, vol. 10, no. 1, article 28, 2013.
85. J. C. Figueiredo, M. V. Grau, K. Wallace et al., "Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 4, pp. 1041-1049, 2009.
86. R. Rebollo, M. T. Romanish, andD. L.Mager, "Transposable elements: an abundant and natural source of regulatory sequences for host genes," Annual Review of Genetics, vol. 46, pp. 21-42, 2012.